The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Plaque Psoriasis Treatment Market Research Report 2024
Synopsis
Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy.
The global Plaque Psoriasis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plaque Psoriasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plaque Psoriasis Treatment.
Report Scope
The Plaque Psoriasis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plaque Psoriasis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plaque Psoriasis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Johnson and Johnson
Amgen
Abbvie
Eli Lilly
Dermira
Novartis
Galectin Therapeutics
Cellceutix
Biogen
Bayer
Segment by Type
Topical Therapy
Phototherapy
Systemic Agents
Biologic Therapies
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plaque Psoriasis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy.
The global Plaque Psoriasis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plaque Psoriasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plaque Psoriasis Treatment.
Report Scope
The Plaque Psoriasis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plaque Psoriasis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plaque Psoriasis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Johnson and Johnson
Amgen
Abbvie
Eli Lilly
Dermira
Novartis
Galectin Therapeutics
Cellceutix
Biogen
Bayer
Segment by Type
Topical Therapy
Phototherapy
Systemic Agents
Biologic Therapies
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plaque Psoriasis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plaque Psoriasis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Topical Therapy
1.2.3 Phototherapy
1.2.4 Systemic Agents
1.2.5 Biologic Therapies
1.3 Market by Application
1.3.1 Global Plaque Psoriasis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plaque Psoriasis Treatment Market Perspective (2019-2030)
2.2 Plaque Psoriasis Treatment Growth Trends by Region
2.2.1 Global Plaque Psoriasis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plaque Psoriasis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Plaque Psoriasis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Plaque Psoriasis Treatment Market Dynamics
2.3.1 Plaque Psoriasis Treatment Industry Trends
2.3.2 Plaque Psoriasis Treatment Market Drivers
2.3.3 Plaque Psoriasis Treatment Market Challenges
2.3.4 Plaque Psoriasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plaque Psoriasis Treatment Players by Revenue
3.1.1 Global Top Plaque Psoriasis Treatment Players by Revenue (2019-2024)
3.1.2 Global Plaque Psoriasis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Plaque Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plaque Psoriasis Treatment Revenue
3.4 Global Plaque Psoriasis Treatment Market Concentration Ratio
3.4.1 Global Plaque Psoriasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plaque Psoriasis Treatment Revenue in 2023
3.5 Plaque Psoriasis Treatment Key Players Head office and Area Served
3.6 Key Players Plaque Psoriasis Treatment Product Solution and Service
3.7 Date of Enter into Plaque Psoriasis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plaque Psoriasis Treatment Breakdown Data by Type
4.1 Global Plaque Psoriasis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Plaque Psoriasis Treatment Forecasted Market Size by Type (2025-2030)
5 Plaque Psoriasis Treatment Breakdown Data by Application
5.1 Global Plaque Psoriasis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Plaque Psoriasis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plaque Psoriasis Treatment Market Size (2019-2030)
6.2 North America Plaque Psoriasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plaque Psoriasis Treatment Market Size by Country (2019-2024)
6.4 North America Plaque Psoriasis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plaque Psoriasis Treatment Market Size (2019-2030)
7.2 Europe Plaque Psoriasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plaque Psoriasis Treatment Market Size by Country (2019-2024)
7.4 Europe Plaque Psoriasis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plaque Psoriasis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Plaque Psoriasis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plaque Psoriasis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Plaque Psoriasis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plaque Psoriasis Treatment Market Size (2019-2030)
9.2 Latin America Plaque Psoriasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plaque Psoriasis Treatment Market Size by Country (2019-2024)
9.4 Latin America Plaque Psoriasis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plaque Psoriasis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Plaque Psoriasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plaque Psoriasis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Plaque Psoriasis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Plaque Psoriasis Treatment Introduction
11.1.4 Allergan Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.1.5 Allergan Recent Development
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Company Detail
11.2.2 Johnson and Johnson Business Overview
11.2.3 Johnson and Johnson Plaque Psoriasis Treatment Introduction
11.2.4 Johnson and Johnson Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.2.5 Johnson and Johnson Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Plaque Psoriasis Treatment Introduction
11.3.4 Amgen Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Abbvie
11.4.1 Abbvie Company Detail
11.4.2 Abbvie Business Overview
11.4.3 Abbvie Plaque Psoriasis Treatment Introduction
11.4.4 Abbvie Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.4.5 Abbvie Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Plaque Psoriasis Treatment Introduction
11.5.4 Eli Lilly Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.5.5 Eli Lilly Recent Development
11.6 Dermira
11.6.1 Dermira Company Detail
11.6.2 Dermira Business Overview
11.6.3 Dermira Plaque Psoriasis Treatment Introduction
11.6.4 Dermira Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.6.5 Dermira Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Plaque Psoriasis Treatment Introduction
11.7.4 Novartis Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Galectin Therapeutics
11.8.1 Galectin Therapeutics Company Detail
11.8.2 Galectin Therapeutics Business Overview
11.8.3 Galectin Therapeutics Plaque Psoriasis Treatment Introduction
11.8.4 Galectin Therapeutics Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.8.5 Galectin Therapeutics Recent Development
11.9 Cellceutix
11.9.1 Cellceutix Company Detail
11.9.2 Cellceutix Business Overview
11.9.3 Cellceutix Plaque Psoriasis Treatment Introduction
11.9.4 Cellceutix Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.9.5 Cellceutix Recent Development
11.10 Biogen
11.10.1 Biogen Company Detail
11.10.2 Biogen Business Overview
11.10.3 Biogen Plaque Psoriasis Treatment Introduction
11.10.4 Biogen Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.10.5 Biogen Recent Development
11.11 Bayer
11.11.1 Bayer Company Detail
11.11.2 Bayer Business Overview
11.11.3 Bayer Plaque Psoriasis Treatment Introduction
11.11.4 Bayer Revenue in Plaque Psoriasis Treatment Business (2019-2024)
11.11.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
